139 related articles for article (PubMed ID: 33820700)
1. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough.
Loizides U; Dominici M; Manderson T; Rizzi M; Robertson JS; de Sousa Guimarães Koch S; Timón M; Balocco R
Cytotherapy; 2021 May; 23(5):357-366. PubMed ID: 33820700
[TBL] [Abstract][Full Text] [Related]
2. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
[TBL] [Abstract][Full Text] [Related]
3. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Robertson JS; Loizides U; Adisa A; López de la Rica Manjavacas A; Rodilla V; Strnadova C; Weisser K; Balocco R
Vaccine; 2022 Jan; 40(1):21-27. PubMed ID: 34844820
[TBL] [Abstract][Full Text] [Related]
4. The INN global nomenclature of biological medicines: A continuous challenge.
Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M
Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314
[TBL] [Abstract][Full Text] [Related]
5. Use of Identical INN "Imiglucerase" for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database.
Tsang SF; Pandya S; Barakov K; Keutzer J; Lewis G; Ross L; Freisens S
Drug Saf; 2022 Feb; 45(2):127-136. PubMed ID: 35020177
[TBL] [Abstract][Full Text] [Related]
6. International Nonproprietary Names (INN) for pharmaceutical substances.
Kopp-Kubel S
Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
[TBL] [Abstract][Full Text] [Related]
7. The INNs and outs of antibody nonproprietary names.
Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
[TBL] [Abstract][Full Text] [Related]
8. How INNs are created. Making drug names safer by contributing to INN selection.
Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
[TBL] [Abstract][Full Text] [Related]
9. What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications.
Serafini M; Cargnin S; Massarotti A; Tron GC; Pirali T; Genazzani AA
J Med Chem; 2021 Apr; 64(8):4410-4429. PubMed ID: 33847110
[TBL] [Abstract][Full Text] [Related]
10. Obstacles to the universal application of INNs.
Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
[TBL] [Abstract][Full Text] [Related]
11. [Development of the database on nonproprietary names of drugs].
Hashiba S; Takenaka Y; Nakadate M
Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
[TBL] [Abstract][Full Text] [Related]
12. Operational rules for the implementation of INN prescribing.
Van Bever E; Wirtz VJ; Azermai M; De Loof G; Christiaens T; Nicolas L; Van Bortel L; Vander Stichele R
Int J Med Inform; 2014 Jan; 83(1):47-56. PubMed ID: 24168761
[TBL] [Abstract][Full Text] [Related]
13. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
[TBL] [Abstract][Full Text] [Related]
14. WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007.
Joung J; Robertson JS; Griffiths E; Knezevic I;
Biologicals; 2008 Jul; 36(4):269-76. PubMed ID: 18218324
[TBL] [Abstract][Full Text] [Related]
15. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
[TBL] [Abstract][Full Text] [Related]
16. Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
Parren PWHI; Carter PJ; Plückthun A
MAbs; 2017; 9(6):898-906. PubMed ID: 28621572
[TBL] [Abstract][Full Text] [Related]
17. Think INN, prescribe INN, dispense INN: good professional practice.
Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
[TBL] [Abstract][Full Text] [Related]
18. International Nonproprietary Names (INN). A World Health Organization activity.
Jerome JB; Luback PM
J Am Med Womens Assoc (1972); 1972 Oct; 27(10):536-8. PubMed ID: 4342347
[No Abstract] [Full Text] [Related]
19. Compendial issues: WHO.
Kopp-Kubel S
J Parenter Sci Technol; 1992; 46(6):201-5. PubMed ID: 1474431
[TBL] [Abstract][Full Text] [Related]
20. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
